News & Updates
Filter by Specialty:
Healthy lifestyle lowers T2D hazard in genetically at-risk individuals
A genetic predisposition to low birth weight and childhood obesity contributes to an increased risk of adult type 2 diabetes (T2D), suggests a study. These risks can be modified by adherence to a healthy lifestyle in adulthood, particularly among those at high genetic risk of childhood obesity.
Healthy lifestyle lowers T2D hazard in genetically at-risk individuals
25 Mar 2022HDL3 cholesterol tied to primary open-angle glaucoma
A causal and specific association exists between high-density lipoprotein (HDL) 3 cholesterol and primary open-angle glaucoma (POAG), suggests a cross-sectional study, noting that dysregulation of cholesterol transport may contribute to the pathogenesis of POAG.
HDL3 cholesterol tied to primary open-angle glaucoma
18 Mar 2022Over-the-counter nutritional supplement may help avert gestational diabetes
Myo-inositol, a nutritional supplement that is present in fruits and fibre-rich foods, shows promise in the prevention of gestational diabetes, as reported in a study.
Over-the-counter nutritional supplement may help avert gestational diabetes
18 Mar 2022Glycaemic control not a risk factor for cerebral small vessel disease in T1D
Among patients with type 1 diabetes (T1D), medium- and long-term blood glucose control and long-term glycaemic variability do not exert any influence on the risk of developing cerebral small vessel disease, a study has found.
Glycaemic control not a risk factor for cerebral small vessel disease in T1D
16 Mar 2022Early menopause tied to increased dementia risk
Individuals who experience menopause before age 50 years may be at an elevated risk of developing dementia, according to results of a UK study presented at the EPI Lifestyle Scientific Sessions 2022.
Early menopause tied to increased dementia risk
15 Mar 2022Empagliflozin lowers blood pressure in T2D
Among hypertensives with type 2 diabetes (T2D), treatment with the sodium-glucose cotransporter 2 inhibitor empagliflozin produces clinically meaningful reductions in blood pressure, reports a recent study.